Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Halozyme Therapeutics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Antares Pharma Inc.

    02 5Antares Pharma, Inc

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    Fi Europe 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Fi Europe 2024
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2009-07-14

    Antares Pharma

    City : Minneapolis

    State : MN

    Country/Area : US

    Zip : 55447-5473

    District : MIN

    Center : CDRH

    Project Area : Compliance: Devices

    District Decision : No Action Indicated

    Inspection End Date : 2009-07-14

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    Fi Europe 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Fi Europe 2024
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2012-09-06

    Antares Pharma

    City : Minneapolis

    State : MN

    Country/Area : US

    Zip : 55447-5473

    District : MIN

    Center : CDRH

    Project Area : Compliance: Devices

    District Decision : No Action Indicated

    Inspection End Date : 2012-09-06

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    Fi Europe 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Fi Europe 2024
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2016-01-21

    Antares Pharma

    City : Minneapolis

    State : MN

    Country/Area : US

    Zip : 55447-5473

    District : MIN

    Center : CDRH

    Project Area : Compliance: Devices

    District Decision : No Action Indicated

    Inspection End Date : 2016-01-21

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    Fi Europe 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Fi Europe 2024
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2016-01-21

    Antares Pharma

    City : Minneapolis

    State : MN

    Country/Area : US

    Zip : 55447-5473

    District : MIN

    Center : CDRH

    Project Area : Postmarket Assurance: Devices

    District Decision : No Action Indicated

    Inspection End Date : 2016-01-21

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    Fi Europe 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Fi Europe 2024
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-12-04

    Antares Pharma

    City : Minneapolis

    State : MN

    Country/Area : US

    Zip : 55447-5473

    District : MIN

    Center : CDRH

    Project Area : Compliance: Devices

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-12-04

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    Fi Europe 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Fi Europe 2024
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2012-08-20

    Antares Pharma

    City : Ewing

    State : NJ

    Country/Area : US

    Zip : 08618-1433

    District : NWJ

    Center : CDRH

    Project Area : Compliance: Devices

    District Decision : No Action Indicated

    Inspection End Date : 2012-08-20

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    FDA Audited

    USA
    Fi Europe 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Fi Europe 2024
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2017-02-27

    Antares Pharma

    City : Ewing

    State : NJ

    Country/Area : US

    Zip : 08618-1433

    District : NWJ

    Center : CDER

    Project Area : Postmarket Surv. and Epidemiolog...

    District Decision : No Action Indicated

    Inspection End Date : 2017-02-27

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Halozyme Therapeutics and get a quotation

    Halozyme Therapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of ENHANZE DRUG PRODUCT bulk with DMF offered by Halozyme Therapeutics